Countries enabled to address antimicrobial resistance through surveillance

prioritization and resource mobilization following a step-wise approach: (i) development of a consensus-based package of antimicrobial resistancepriority interventions across One Health sectors, cost and return on investment, (ii) customizing the newly developed priority package of multisectoral interventions, a toolbox for costing and estimation of return on investment to different countries; and (iii) supporting the development of countries investment cases and resource mobilization for implementation of national action plans; develop, prioritize, cost, fund, implement and monitor multisectoral national action plans on antimicrobial resistance, including by establishing functional national multisectoral coordination mechanisms that engage all relevant sectors, are adequately resourced, and are accountable for implementation of the antimicrobial resistance national action plan; establish a people-centred package of core interventions for human health in the antimicrobial resistance national action plan; raise public awareness through targeted efforts, including through World Antimicrobial Awareness Week campaigns, nationwide campaigns targeting secondary school students and youth, the use of social media and targeted behaviour change campaigns, such as for the prescription and use of antimicrobials; establish multidisciplinary antimicrobial stewardship programmes and practices, including by developing national integrated policies and related capacity-building for health care workers; strengthen functions of regulatory authorities for medicines (including collaboratively for human and veterinary medicines) based on the 2021 Access, Watch, Reserve (AWaRe) classification in national essential medicines lists, formularies and treatment guidelines, and to phase out over-the-counter sales of antibiotics; develop policies to address recurrent shortages of essential antimicrobial medicines and diagnostics; and promote equitable access to quality-assured essential antibiotics and diagnostic tools, including to access essential newly-approved Reserve antibiotics and generic off-patent antibiotics in short supply; support implementation of national regulations on antimicrobial sale, use, dispensing and disposal; enhance pre-service and in-service training for health workers, and for medical and health science students, support the development of standard curricula and promote the inclusion of women and disadvantaged sections of the population, including migrant and refugee populations, in awareness and training efforts; establish, strengthen, and scale up national and regional integrated systems for antimicrobial resistance surveillance with relevance to human health using the Global Antimicrobial Resistance and Use Surveillance System (GLASS);